Cancer Immunotherapy Research Engineer
Kompetansekart
Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Benefits offered by this job
Job summary
The research engineer position in the targeted therapies and immunomodulation group led by Prof. Mouldy Sioud at Oslo University Hospital-Radiumhospitalet focuses on developing cancer therapeutics, including antibodies and mRNA cancer vaccines.
You will design and conduct in vitro and in vivo experiments and analyze data. The appointment is for one year with potential extension; requires a Master's in a relevant field and hands-on experience in molecular biology, flow cytometry, and protein
Qualifications
- Master's degree in molecular biology, cell biology, biotechnology, immunology, or a related field.
- Hands-on experience in molecular and cellular biology techniques (cell culture, transfection, cloning, protein analysis).
- Experience with flow cytometry, immunoprecipitation, and protein purification is highly desirable.
- Good communication skills in English and ability to work independently and collaboratively.
Responsibilities
- Design and conduct a range of in vitro and in vivo experiments, analyse experimental data, and contribute to scientific publications.
- Identify cell-surface receptors involved in antibody binding to cancer cells and enhance the efficacy of mRNA-based cancer vaccines through mRNA modifications.
Skills
Education
Job description
The research engineer position in the targeted therapies and immunomodulation group led by Prof. Mouldy Sioud at Oslo University Hospital-Radiumhospitalet focuses on developing cancer therapeutics, including antibodies and mRNA cancer vaccines.
You will design and conduct in vitro and in vivo experiments and analyze data. The appointment is for one year with potential extension; requires a Master's in a relevant field and hands-on experience in molecular biology, flow cytometry, and protein
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
